Tuesday, 28 January 2020

Palliative Care market 2020 - current and future plans 2023

Global Palliative Care Market, Type (Private Resident Care, Hospital Inpatient Care, Nursing Home and Residential Facility Center, and Others), by Application (Cancer, Kidney Failure, and Others), by End-User (Hospitals, Palliative Care Centers, and Others) Forecast to 2023
Market Scenario 
Palliative care helps to improve the quality of life of patients and their families facing the problems of serious illness. The main focus of Palliative care is to provide relief from symptoms and stress of a serious illness. Their main goal is to improve the quality of life for both the patient and the family. Palliative care treats people living with a serious illness such as cancer, cardiac diseases such as congestive heath failure, kidney failure, Alzheimer’s and many more. It improves the quality of life of the patient and supports the primary physician, patient, and family. In last 15 years, the Palliative care market has a stunning growth and the factors that have led to the growth of this market are growing the aging population, increase in chronic life-threatening disease, initiative taken by the government and non- profit organization, and rise in government funding.  
Global Palliative Care market is expected to grow during the forecast period at a CAGR ~8.1 %.
Increasing incidence of diseases such as cancer, cardiovascular and infective disease are some of the drivers responsible for the market growth of global palliative care market. Other factors such as a growing number of palliative care centers worldwide, expanding aging demographics, increasing number of qualified physicians for palliative care are responsible for the rise in the global palliative market. The main object of palliative care is to enhance personal satisfaction for both the patient and family. This palliative care can be provided at any age and at any phase in a genuine ailment and can be furnished alongside remedial treatment.
However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.
But the high cost of treatment, less private or public funding to hospital facilities and other medical centers can be a major restraint for the growth of the global palliative care market trends.
Key Players
  • Vitas Healthcare Corporation
  • Skilled Healthcare Group Incorporated
  • Sunrise Senior Living LLC
  • Kindred Healthcare Incorporated
  • Gentiva Health Services Incorporated
  • Home Instead Senior Care Incorporated
  • Amedisys Incorporated
  • Genesis HealthCare Corporation
Segmentation
The Global Palliative Care Market is segmented into types such as private residence care, hospice inpatient care, hospital inpatient care, nursing home and residential facility care and others. On the basis of application, the market is further segmented into cancer, cardiac diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and many more. On basis of end-user, the market is further segmented into hospitals, home care settings, palliative care centers, long-term care centers & rehabilitation centers.
Regional Analysis
In terms of market value, North America will dominate the Palliative care market during the forecast period. Increasing incidences of life-threatening illness such as cancer, cardiovascular diseases, Alzheimer’s disease, kidney failure, chronic obstructive pulmonary disease and many more are some of the factors which are responsible for the growth of the market during the forecast period. In 2015 on average 90 % of US hospitals containing 300 beds or more provide Palliative care services to their patients. This has led to the growth of the market in coming years. The European market is expected to be the second-largest Palliative care market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of Palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for Palliative care center and expanding aging demographics are some of the factors responsible for the rise in the global Palliative care market. Asia-Pacific is expected to be the fastest-growing Palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global Palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global Palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
The market has been segmented, by region, into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Global Palliative Care Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Global Palliative Care Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Global Palliative Care Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Palliative care market in the Middle East and Africa has been segmented into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Digital Wound Measurement Devices market - demand, growth, opportunities, latest trends and drivers during 2020 to 2023

Global Digital Wound Measurement Devices Market Research Report, by Wound Type (Diabetic Ulcers, Incisional, Traumatic, Chronic), Product (Contact Wounds, Non-Contact Wound Measuring Devices), End-User (Hospital and Clinics) – Global Forecast Till 2023
Market Scenario
The global digital wound measurement devices market size is expected to witness a positive growth during the forecast period. Digital wound measurement devices enable monitoring of chronic wounds and deliver the appropriate drug dose to speed up the process of healing. Chronic wounds if not treated on time can lead to severe infections and amputations. Hence, digital wound measurement devices allow delivering tailored treatments after the 2D or 3D assessment of the infection and inflammation. The increasing number of patients suffering from chronic wounds drives the market growth. According to the Intermountain Healthcare (2017), 6.5 million people in the US suffer from chronic wounds. Diabetic wounds are severe, and the process of healing is very long and eventually may lead to amputations. Hence factors such as growing diabetic patients, rising geriatric population, and an increasing number of surgeries are major factors influencing the growth of the market. The emergence of smartphones, rapid use of advanced digital tools, and the advent of telehealth for wound care will also contribute for the market to grow.
However, factors such as, the inability of the device to provide additional information about wounds such as moistness or exudation and high costs of digital devices are expected to restrict the market growth during the forecast period.
Key Players
  • WoundRight Technologies Tissue Analytics
  • Parable Health
  • ARANZ Medical Limited
  • eKare, Inc,
  • KCI,
  • an Acelity Company,
  • WoundMatrix, Inc.,
  • WoundZoom Inc.,
  • Kent Imaging Inc.,
  • WoundRight Technologies, LLC,
  • WoundVision, LLC,
  • Hitachi Healthcare Americas,
  • Smith & Nephew plc.
Segmentation
The global digital wound measurement devices market is segmented on the basis of wound type, product, and end-user. The digital wound measurement devices market, by wound type is sub-segmented into a diabetic ulcer, chronic wounds, burns, incisional, and traumatic. The product segment is sub-segmented into contact wound measuring devices and non-contact wound measuring devices.
On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
On the basis of region, the global digital wound measurement devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Regional Market
Asia-Pacific was projected to be the fastest growing region for the global digital wound measurement devices market. Key factors such as rising geriatric population, growing diabetic patient pool, high incidence chronic wounds, and developing healthcare infrastructure drive the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world diabetic population is in Asia. This provides favorable backgrounds for the market to grow in Asia.
The digital wound measurement devices market is dominated by North America owing to the rising prevalence of chronic wounds and technological advancements in the healthcare sector.  In June 2018, KCI, an Acelity Company announced the launch of Nurse2Nurse (N2N) Mobile App for wound care nurses. The app allows interactions with clinicians and shares credible insights and information for better patient care.
It is estimated that Europe was the second largest in the global digital wound measurement devices market. The increasing technological advancement and research for wound care along with government support in Europe drive the market growth in this region. The European Wound Management Association will conduct its 29th conference by June 2019 in Gothenburg, Sweden in the presence of several international wound management communities with the common goal of improving the care of wound patients.
The Middle East and Africa holds the least share of the global digital wound measurement devices market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investments by private market players in this region can boost the market growth. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Colposcopy market share, opportunities, segmentation and forecast to 2023

Global Colposcopy Market Research Report: Instrument Type (Optical Colposcope, Digital Colposcope), Instrument Portability (Portable, Fixed, Handheld), Application (Cancer Screening, Examinations), Magnification Type, End-User – Global Forecast Till 2023
Market Scenario
A colposcope is basically a surgical instrument similar to an electric microscope with a source of light that allows gynecologists to examine the vagina and cervix more clearly and under proper magnification. The rising prevalence of cervical cancer around the globe is the primary factor driving the growth of the colposcopy market.
For instance, according to the World Health Organization (WHO) in 2017, cervical cancer is the second most reason for the death of women worldwide. Currently, awareness programmes are conducted by numerous NGOs focusing on health-related issues in women such as cervical cancer which will increase the demand for colposcopes.
The Colposcopy Market Forecast 2020 asserts the market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global colposcopy market is expected to register a CAGR of ~6.8% during the forecast period, 2018–2023.
Despite these drivers, factors such as high installation cost of this device and lack of skilled clinical users to operate colposcopes are likely to restrain the growth of the market.
Company Profiles            
  • Carl Zeiss
  • Olympus Corporation
  • Danaher Corporation
  • Philips Healthcare
  • CooperSurgical
  • McKesson Corporation
  • DYSIS Medical
  • Atmos
  • Alliton
  • Seliga Microscopes
  • Karl Kaps
  • Bovie Medical
Segmentation
The global colposcopy market is segmented on the basis of instrument type, instrument portability, application, and end-users.
On the basis of instrument type, the market is classified into optical colposcopes and digital colposcopes.
On the basis of instrument portability, the market is classified into portable, fixed, and handheld.
On the basis of application, the market is classified as cervical cancer screening, physical examinations, and others.
On the basis of magnification type, the market is classified into fixed magnification and variable magnification
On the basis of end-user, the market is classified into hospitals, clinics, diagnostic centers, and others.
Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American colposcopy market is further segmented into North America and South America. North America is further classified as the US and Canada.
The European colposcopy market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. 
The colposcopy market in Asia-Pacific is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific.
The Middle Eastern and African colposcopy market is segmented into the Middle East and Africa.
Regional Market Summary
Asia-Pacific is the fastest growing region in the market owing to the increasing cases of cervical cancer in the region, growing demand for cervical cancer screening, and rising healthcare expenditure in Asian countries. Additionally, according to a study published in the World Health Organization (WHO) in 2017, every year cervical cancer kills more than 250000 women, and 85% of these deaths occur in low- and middle-income countries. Furthermore, the rapid development of economies and increasing healthcare expenditure have fuelled the growth of the market.
The Americas is likely to dominate the global colposcopy market owing to technological advancements in colposcopes such as high-quality video and improved accuracy in detection. For instance, the American Cancer Society in 2018, estimated about 13,240 new cases of invasive cervical cancer to be diagnosed in the US with nearly 4,170 women dying from cervical cancer. Furthermore, continuous development of advanced colposcopy by manufacturers in the region contributes to the market growth.
Europe is likely to hold the second position in the global colposcopy market. It is expected that the favorable reimbursement scenario is responsible for the ambient growth in this region. Additionally, according to the Cancer Research UK in 2017, more than 3000 new cases of cervical cancer are diagnosed in the UK each year.  
The Middle East and Africa accounts for the lowest market share in the global colposcopy market owing to the lack of awareness regarding cervical cancer in the MEA region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora, Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Electronic Pill market 2020 global trend, segmentation and opportunities forecast to 2023

Global Electronic Pill Market Research Report, By Application (Capsule Endoscopy, Drug Delivery), Target Area (Oesophagus, Stomach), Parts (Biocompatible Capsule Encasing Microsensors), End-User (Diagnostics Centers, Hospitals) – Global Forecast Till 2023
Market Scenario
Electronic pills are equipped with sensors and cameras which allow capturing of several images of the gastrointestinal tract. They are used for diagnostic purposes and are increasingly replacing traditional diagnostic methods. It further monitors various parameters such as temperature, conductivity, pH, and dissolved oxygen. Market Research Future (MRFR) has thoroughly studied the trends and patterns governing the global electronic pills market over the forecast period of 2018-2023 in a detailed study. MRFR projects a CAGR of 15% within the electronic pills market over the forecast period.
Towering prevalence of gastrointestinal disorders has driven the market for electronic pills. Electronic pills alleviate tedious and painful diagnostic procedures such as colonoscopy and endoscopy and provide accurate results without much discomfort to the patient. Surging cases of stomach cancer coupled with increasing preference for minimally invasive medical procedures is likely to augment the growth of the electronic pills market trends. Healthcare professionals are increasingly adopting theses pills as they facilitate on-site diagnosis. Other factors which contribute to the growth of the market include improving reimbursement scenario and rise in global geriatric population who are more susceptible to various chronic diseases. Additionally, capsule endoscopy has gained widespread adoption as a non-invasive diagnostic method which is likely to fuel the growth of the market over the forecast period. On the contrary, the growth of the electronic pills market can be impeded by factors such as lack of awareness, capsule retention, and bowel obstruction. Moreover, high costs aligned with electronic pills and regulatory restrictions are anticipated to hinder the growth of the market.
Segmentation
The global electronic pill market has been segmented based on application, target area, part, and end user.
By application, the electronic pill market has been segmented into capsule endoscopy, drug delivery, and patient monitoring.
By target area, the electronic pill market has been segmented into oesophagus, stomach, small intestine, and large intestine.
By part, the electronic pill market has been segmented into biocompatible capsule encasing microsensors, control chip, radio transmitter and power source.
By end user, the electronic pill market has been segmented into Hospitals, diagnostic centers, clinical research organizations, and medical centers.
Regional Analysis
By region, the electronic pill market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
In 2017, the global electronic pill market was led by the Americas. The dominance of the Americas market can be attributed to the surging prevalence of gastrointestinal diseases, vigorous R&D activities and fast uptake of the latest technologies in the region.
Europe follows the Americas closely and is estimated to showcase substantial growth over the forecast period. Escalating cases of gastric cancer and high demand for diagnostics services is fuelling the growth of the market.
The APAC electronic market is likely to witness the fastest growth over the forecast period. The growth of the market can be attributed to increasing patient population, growing medical tourism in the region, and extensive R&D activities and high investment by the governments in the region create a conducive environment for the growth of the market 
The MEA market accounts for the least share of the electronic pill market. The growth of the market might be restrained by stringent government policies and poor economic conditions.
Competitive Landscape
Medtronic, JINSHAN Science & Technology, Medimetrics (Mexico), Medisafe, CapsoVision, Inc. (US), Given Imaging Ltd. (Israel), (Bio-Images Drug Delivery) BDD LTD (UK), Proteus Digital Health (US), Olympus Corporation, and INTROMEDIC are the distinguished players in the electronic pill market.
Industry Updates
February 2019 - a new electronic pill equipped with Wi-Fi transmitter has been developed which is capable of harvesting energy from inside a patient's stomach and record core body temperature and then send data to an external monitor.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Immunofluorescence Assay market segments, opportunity, growth and forecast by end-use industry, key competitors and market value 2020

Market Scenario
The growing prevalence of chronic and infectious diseases increase in research and development activities, growing government investments for R&D activities, increased need for rapid and sensitive diagnostics, and adoption of technologically advanced systems are the key factors for the market to grow. However, factors such as, expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.
The Global Immunofluorescence Assays Market Size is expected to reach an approximate CAGR of 5.8% during the forecast period.
According to National Institutes of Health (2012), autoimmune diseases are most prevalent among other diseases, and 23.5 million people in America suffer from autoimmune diseases, whereas 9 million people have cancer. Furthermore, according to Alzheimer's Association in 2018, 5.7 million Americans are affected by Alzheimer’s disease.  Thus, such high incidence of autoimmune and neurological diseases and increasing government funding enhances the growth in this market. Also, growing demand for rapid and precise measurement of biomolecules, increased use of Immunofluorescence Assay for diagnostic and research purposes, increased R&D activities and advanced technology are the key factors for the market to grow.
However, factors such as expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.
Key Players
Some of the key players for the global Immunofluorescence Assay market are Abcam plc, Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc.,BioTek Instruments,Inc., Bio-Rad Laboratories, Inc., Zyagen, Cell Signaling Technology, Inc., PerkinElmer Inc. Becton Dickinson and Company , Merck , Agilent Technologies , TCS Biosciences Ltd, Maxvision Biosciences Inc. and Others.
Segmentation
The global immunofluorescence assay market is segmented on the basis of technique, product type, application and end user. The immunofluorescence assay market, by technique is sub segmented into primary (direct) immunofluorescence assays, secondary (indirect) immunofluorescence assays, and micro immunofluorescence. Secondary (indirect) immunofluorescence assays category includes salt split technique, antigenic mapping method and double staining method. On the basis of product type, the market is categorized into antibodies, kits and reagents, instruments, labelling dyes and species type. Instruments is further sub segmented into microscopes and imaging analysis systems. The application segment includes clinical research, clinical diagnostics, research & development. Clinical diagnostics segment is categorized into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, neurological diseases. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and diagnostic centers.
Browse Immunofluorescence Assay Research Report by Technique, by Product Type, by Application, End-User @ https://www.marketresearchfuture.com/reports/immunofluorescence-assay-market-6177 
Regional Market Summary
The Immunofluorescence Assay market is dominated by North America owing to the high prevalence of chronic diseases and high R&D investments within this region stimulate market growth. According to the U.S. Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of diseases drives the market growth in this region.
It is estimated that Europe stood second in the global Immunofluorescence Assay market. Rising prevalence of chronic diseases such as cancer is driving the growth of this market in Europe. According to the Eurostat in 2014, 272 thousand people deaths were due to lung cancer. Thus, increasing prevalence of cancer in Europe drives the market growth. Furthermore, rapidly growing biotechnology sector in Europe is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global Immunofluorescence Assay market. Key factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in biotechnology sector influences the market in this region. Also, the presence of major market players China, India, and Japan drive the market growth.
The Middle East and Africa holds the least share in the global Immunofluorescence Assay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Carcinoid Syndrome Management market, segments, growth and value chain 2020

Market Scenario:
Dental cone beam computed tomography (CT) is a special type of x-ray equipment used when regular dental or facial x-rays are not sufficient. The technology is used to produce three dimensional (3-D) images of the teeth, soft tissues, nerve pathways and bone in a single scan. The CBCT dental imaging industry is growing rapidly. The increasing use of 3D radiographic imaging in orthodontics and increasing adoption of CBCT imaging by dental professionals has boosted the revenue of this market. 
The U.S., India & Europe market is expected to reach USD 565.3 million by the end of the forecast period due to rising CBCT Dental Imaging Market Trends and is expected to grow at a CAGR of 9.8%.
Key Finding
  • The U.S., India & Europe CBCT dental imaging market and is expected to reach USD 565.3 million by 2023.
  • Regionally, U.S. holds the largest market share of U.S., India & Europe CBCT dental imaging market and is expected to reach USD 280.9 million by 2023.
  • India market is expected to be the fastest growing market, and expected to grow at a CAGR of 10.3% from 2016 to 2023
Key Players for U.S., India & Europe CBCT dental imaging market:
Some of the key players in this market are: Carestream Health (US), Dentsply Sirona (US), FONA Dental, S.R.O., Gendex, Imaging Sciences International, LLC (US), J.MORITA MFG.CORP. (Japan), KaVo Dental GmbH (Germany), NewTom, Planmeca OY, Prexion (US), Sinclair Dental/Dentaire (Canada), SOREDEX (Finland), Vatech Networks (Republic of Korea) and others.
Segments:
U.S., India & Europe CBCT dental imaging market has been segmented on the basis of type of detector which comprises of flat panel detectors, image intensifier. On the basis of application the market is segmented into dental implants, endodontics, orthodontics and others. On the basis of end users the market is segmented into hospitals & dental clinics, academic & research institutes and others.
Regional Analysis of U.S., India & Europe CBCT dental imaging market:
U.S. is the largest market for CBCT Dental Imaging market. The U.S. market for CBCT dental imaging is expected to grow at a CAGR of 9.5% and is expected to reach at USD 280.9 Million by the end of the forecast period.
Europe is the second-largest market for CBCT dental imaging which is expected to grow at a CAGR of 10.0%. India region is expected to be fastest growing region in CBCT dental imaging market.
The report for U.S., India & Europe CBCT Dental Imaging Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

CBCT Dental Imaging market revenue, opportunity, forecast and value chain 2020

Market Scenario:
Dental cone beam computed tomography (CT) is a special type of x-ray equipment used when regular dental or facial x-rays are not sufficient. The technology is used to produce three dimensional (3-D) images of the teeth, soft tissues, nerve pathways and bone in a single scan. The CBCT dental imaging industry is growing rapidly. The increasing use of 3D radiographic imaging in orthodontics and increasing adoption of CBCT imaging by dental professionals has boosted the revenue of this market. 
The U.S., India & Europe market is expected to reach USD 565.3 million by the end of the forecast period due to rising CBCT Dental Imaging Market Trends and is expected to grow at a CAGR of 9.8%.
Key Finding
  • The U.S., India & Europe CBCT dental imaging market and is expected to reach USD 565.3 million by 2023.
  • Regionally, U.S. holds the largest market share of U.S., India & Europe CBCT dental imaging market and is expected to reach USD 280.9 million by 2023.
  • India market is expected to be the fastest growing market, and expected to grow at a CAGR of 10.3% from 2016 to 2023
Key Players for U.S., India & Europe CBCT dental imaging market:
Some of the key players in this market are: Carestream Health (US), Dentsply Sirona (US), FONA Dental, S.R.O., Gendex, Imaging Sciences International, LLC (US), J.MORITA MFG.CORP. (Japan), KaVo Dental GmbH (Germany), NewTom, Planmeca OY, Prexion (US), Sinclair Dental/Dentaire (Canada), SOREDEX (Finland), Vatech Networks (Republic of Korea) and others.
Segments:
U.S., India & Europe CBCT dental imaging market has been segmented on the basis of type of detector which comprises of flat panel detectors, image intensifier. On the basis of application the market is segmented into dental implants, endodontics, orthodontics and others. On the basis of end users the market is segmented into hospitals & dental clinics, academic & research institutes and others.
Regional Analysis of U.S., India & Europe CBCT dental imaging market:
U.S. is the largest market for CBCT Dental Imaging market. The U.S. market for CBCT dental imaging is expected to grow at a CAGR of 9.5% and is expected to reach at USD 280.9 Million by the end of the forecast period.
Europe is the second-largest market for CBCT dental imaging which is expected to grow at a CAGR of 10.0%. India region is expected to be fastest growing region in CBCT dental imaging market.
The report for U.S., India & Europe CBCT Dental Imaging Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com